Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
RGDO > SEC Filings for RGDO > Form 8-K on 5-May-2014All Recent SEC Filings

Show all filings for REGADO BIOSCIENCES INC



Entry into a Material Definitive Agreement, Change in Directors or Princip

Item 1.01 Entry into a Material Definitive Agreement.

On April 30, 2014, Regado Biosciences, Inc. (the "Company") entered into an Office Lease (the "Lease") with 106 Allen Road, LLC (the "Landlord") pursuant to which the Company leased up to 18,467 rentable square feet of office space from the Landlord at 106 Allen Road, Basking Ridge, New Jersey. The Company will use the office space as its new corporate headquarters. The term of the Lease will commence on August 1, 2014 and will expire on July 31, 2020 (the "Term"). The Lease provides for, among other things, monthly base rent during the Term in the amounts set forth in the table below, which assumes that the Company is not in default of the Lease, plus additional rent as described in the lease.

             Start Date             End Date        Monthly Base Rent
             August 1, 2014     January 31, 2015   $              0.00
             February 1, 2015   January 31, 2016   $         25,000.00
             February 1, 2016   January 31, 2017   $         31,875.00
             February 1, 2017   January 31, 2018   $         40,011.83
             February 1, 2018   January 31, 2019   $         40,781.29
             February 1, 2019   July 31, 2020      $         41,550.75

The foregoing summary of the Lease does not purport to be complete and is qualified in its entirety by reference to the complete Lease, which is attached as Exhibit 1.1 and incorporated herein by reference.

Item 5.02 Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers; Compensatory Arrangements of Certain Officers.

Decision to Retire and Not Stand For Reelection of Director

On May 5, 2014, RaphaŽl Wisniewski notified Regado Biosciences, Inc., (the "Company") of his decision to retire and not stand for reelection to the Board of Directors of the Company (the "Board") at the Company's 2014 Annual Meeting of Stockholders (the "Annual Meeting"). Mr. Wisniewski will continue to serve as a Class I Director and a member of each of the Audit Committee and the Nominating and Corporate Governance Committee of the Board until the Annual Meeting. Mr. Wisniewski attributed his decision to the fact that travelling from his home and principal business location in France to the Company's Board meetings has become burdensome. Mr. Wisniewski indicated that his decision not to stand for reelection was not a result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.

The Nominating and Corporate Governance Committee of the Board has decided to nominate Andrew J. Fromkin to stand for election as a Class I Director at the Annual Meeting in place of Mr. Wisniewski.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  No.                                     Description

1.1          Office Lease by and between Regado Biosciences, Inc. and 106 Allen
             Road, LLC, dated April 30, 2014.

  Add RGDO to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for RGDO - All Recent SEC Filings
Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.